ANCA

Test/Investigation

ANCA

Site(s) or Laboratory offering Test/Investigation

NNUH (Immunology)

Units

IU/mL

Also Known as/Frequency of Test

Neutrophil Cytoplasmic Antibodies, MPO/PR3; c-ANCA; p-ANCA

Indications

Anti-MPO antibodies (often associated with a pANCA pattern): Commonly associated with microscopic polyangiitis (MPA) and rapidly progressive glomerulonephritis (RPGN). They are also found in approximately 60% of cases of eosinophilic granulomatosis with polyangiitis (EGPA). Anti-PR3 antibodies (often cANCA pattern): Most strongly associated with granulomatosis with polyangiitis (GPA), but may also occur in MPA and EGPA. New positive MPO/PR3 will have an ANCA test by indirect immunoflourescence.

Comments/Precautions

ANCA immunoflourescence is performed at the discretion of the laboratory and can be added in unusual cases of ANCA positivity.

Sample type

Serum

Turnaround times (TAT) Urgent/Routine/GP or OPD

3 working days

Reference intervals (adult unless stated)

MPO <3.5 IU/mL Negative
3.5 – 5.0 IU/mL Equivocal
>5.0 IU/mL Positive. PR3 <2.0 IU/mL Negative
2.0 – 3.0 IU/mL Equivocal
>3.0 IU/mL Positive
ANCA immunofluorescence Negative

If UKAS Accredited Test indicate at which site

Y NNUH